VitaVitro Biotech logo — Advancing IVF solutions for tomorrow's families.

VitaVitro Biotech

Advancing IVF solutions for tomorrow's families.

Founded 2015 China Shenzhen, China 10 employees Series C Total: $15.50M Biotechnology, Health Care

General Information

Company Name VitaVitro Biotech
Founded Year 2015
Location China Shenzhen, China
Employees 10
Industries Biotechnology, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with VitaVitro Biotech. To contact VitaVitro Biotech, visit vitavitro.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VitaVitro Biotech compare?

A PDF of VitaVitro Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VitaVitro Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About VitaVitro Biotech

VitaVitro Biotech is a cutting-edge biotechnology startup based in China, founded in 2015. The company is dedicated to advancing IVF solutions for tomorrow's families with its superior vitrification methods. With its slogan "Advancing IVF solutions for tomorrow's families," VitaVitro is committed to raising standards in IVF technology. Through a robust R&D operation guided by top global expertise, the company aims to modernize IVF processes. In September 2020, VitaVitro Biotech secured a significant $15.50M Series C investment led by Med-Fine Capital and China Capital Investment Group, demonstrating strong investor confidence in its potential to revolutionize the biotechnology and healthcare industries.

Business keywords: IVF technology, vitrification methods, R&D operation, modernization of IVF processes, family planning, reproductive technology, innovation in fertility treatments, medical advancements, global expertise, fertility solutions, family healthcare, reproductive health, biomedical engineering, medical research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $15.50M 2
Med-Fine Capital, China Capital Investment Group
07 Sep 2020

VitaVitro Biotech Alternatives & Competitors

VitaVitro Biotech vs

Artificial Intelligence for Personalized Reproductive Medicine.

Series A
39 employees
AI, Biotechnology
VitaVitro Biotech vs
Ivy Natal
Ivy Natal United States

Unlocking human fertility. Learn more at https://www.ivynatal.com.

Venture round
4 employees
Biotechnology, Health Care
VitaVitro Biotech vs
Paterna Biosciences
Paterna Biosciences United States

From infertility to fatherhood

Seed
23 employees
Biotechnology, Health Care

FAQ About VitaVitro Biotech

Advancing IVF solutions for tomorrow's families.
VitaVitro Biotech was founded in 2015.
VitaVitro Biotech is headquartered in Shenzhen, China.
VitaVitro Biotech operates in Biotechnology and Health Care. Its work centres on IVF technology, vitrification methods, R&D operation and modernization of IVF processes.
VitaVitro Biotech has approximately 10 employees.
VitaVitro Biotech has completed 1 funding round, raising a total of $15.50M. The latest funding stage is Series C.
Top alternatives and competitors to VitaVitro Biotech include Future Fertility, Ivy Natal, Paterna Biosciences, Regenex Corporation Co. Ltd., Clinatec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VitaVitro Biotech and Future Fertility are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VitaVitro Biotech, https://bouncewatch.com/company/vitavitro-biotech, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes